Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 14, 2005

View Archived Issues

sanofi pasteur signs pandemic flu vaccine contract with French Government

Pain Therapeutics and King sign agreement for Remoxy

Discovery Partners International receives milestone payment from Seikagaku

Orphan drug designation for picoplatin in SCLC

Antares Pharma signs ATD gel development agreement with derma company

Cellegy amends European licensing agreement for Rectogesic with ProStrakan

Sontra receives Army grant for SonoPrep dengue vaccine development

FDA approves intravenous administration of Oncaspar

ProEthic holds pre-IND meetings for fast-acting diclofenac products

MCT-465 nominated as lead drug candidate for study in H5N1 avian flu model

Quest PharmaTech to investigate ACP-SL017 for hair removal and acne

BioMarin rounds up Q3 events

Femtomolar concentrations of DPI protect against inflammation and neurotoxicity in vitro

SSR-180575 ameliorates the neurodegenerative effects of FALS

Fast track designation for Proxinium in head and neck cancer

FG-2216 shows promise for anemia of cancer

PK profiling of Hematide in clinical and preclinical studies

XIAP gene therapy for motor neuron diseases

New therapeutics for cancer disclosed in recent patents

Pixantrone reported to increase the efficacy of rituximab in indolent NHL

HCV-796 reduces viral load of patients with chronic HCV infection

Recent patents cover novel agents for respiratory disorders

Phase I data on the pharmacokinetics and safety of CR-002

Therapeutic benefits reported for SPP-301 in diabetic nephropathy patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...